| Literature DB >> 26488809 |
Natasha Whibley1, Sarah L Gaffen2.
Abstract
Interleukin-23 (IL-23) is considered a critical regulator of IL-17 in lymphocytes. Whereas antibodies targeting IL-23 ameliorate colitis, IL-17 neutralization exacerbates disease. In this issue, Cua and colleagues and Maxwell and colleagues show that IL-17 maintains intestinal barrier integrity, helping explain this dichotomy (Lee et al., 2015; Maxwell et al., 2015).Entities:
Mesh:
Substances:
Year: 2015 PMID: 26488809 PMCID: PMC4804829 DOI: 10.1016/j.immuni.2015.10.001
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745